• Cost-of-Illness and Treatment Patterns of Gynecologic Cancer in the United States- An Empirical Analysis Based On MEPS Database 2007-2014

    May 1, 2018, 00:00

  • Characterizing Patients Treated With Macitentan For Pulmonary Arterial Hypertension (PAH) In The U.S. Opsumit Users Registry (OPUS)

    May 1, 2018, 00:00

  • Adherence to Antiretrovirals in Medicaid-Insured Patients Living with HIV- Predictors and Economic Consequences

    May 1, 2018, 00:00

  • Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region

    May 1, 2018, 00:00

  • A 2-Arm Randomized Pilot Study To Evaluate The Impact Of A Mobile Health Application On Medication Adherence In Patients On Oral Anti-Cancer Medications

    May 1, 2018, 00:00

  • Ultrasound- A Fast Low-Cost Tool for the Diagnosis of Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • A Prediction Model for Length of Stay in the Icu Among Septic Patients- A Machine Learning Approach

    May 1, 2018, 00:00

  • Colorectal Cancer Screening Pilot Program Results In Hungary

    May 1, 2018, 00:00

  • Clinical, Humanistic, and Economic Burden of Osteoarthritis (OA) Among Noninstitutionalized Adults in the United States (US)

    May 1, 2018, 00:00

  • Evaluation of the Cost Per Patient Achieving Composite and Single Treatment Targets with Once-Weekly Semaglutide and Exenatide ER in the United States

    May 1, 2018, 00:00

  • Burden of Hospitalization In Lung Cancer Patients with Brain Metastases- Analysis Of US National in-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • A Method to Use Administrative Claims to Categorize Dementia Cases by Subtype

    May 1, 2018, 00:00

  • Improved Quality Control With Subcutaneous (SC) Infusion Pump

    May 1, 2018, 00:00

  • Assessing Symptom Change at the Individual Level Using Item Response Theory Versus Sum Scoring- Implications for Depression Treatment

    May 1, 2018, 00:00

  • Harnessing Big Data- A Methodological Approach to Linking Electronic Health Records with Patient-Reported Survey Data

    May 1, 2018, 00:00

  • Linkage Between Orthopedic Registry and Administrative Data Using Indirect Identifiers for National Device Infrastructure Development

    May 1, 2018, 00:00

  • Using Real World Data to Establish An Optimal Treatment Target for HBA1C in Diabetes Type 2

    May 1, 2018, 00:00

  • Comparison of Healthcare Resource Utilization (HRU) and Costs Related to Pleural Effusion (PE) Between Patients Newly Diagnosed with Chronic Myeloid Leukemia (CML) Treated with Dasatinib or Nilotinib as First-Line Therapy in the United Stat ...

    May 1, 2018, 00:00

  • Health Technology Assessment of Gene Therapies for Inherited Genetic Disorders in the US and Europe

    May 1, 2018, 00:00

  • The Impact of Online Patient Communities on Patient Outcomes- A Systematic Review

    May 1, 2018, 00:00

  • Feminine Hygiene Product Use and Awareness Among Young Us Adults

    May 1, 2018, 00:00

  • Health Utility of Hospitalized Stroke Patients in Vietnam, Comparing Early Stage to Discharge

    May 1, 2018, 00:00

  • The Association Between Airflow Limitation and Early Retirement Using the Health Retirement Survey Data

    May 1, 2018, 00:00

  • Once Daily Vibegron Improves Quality of Life Measures in Patients with Overactive Bladder

    May 1, 2018, 00:00

  • Armed Conflict and Infant Mortality Due to Diarrhea in Colombian Children

    May 1, 2018, 00:00

  • Quantitative Assay of Fecal Calprotectin in Children with Cow’s Milk Protein Allergy

    May 1, 2018, 00:00

  • The Economic Burden of Erectile Dysfunction and Related Comorbidities- A Medicare Perspective

    May 1, 2018, 00:00

  • What’s the Burden of Burden of Illness Reviews?

    May 1, 2018, 00:00

  • Management of Biosimilars- Key Considerations for Pharmacists in Patient Care

    May 1, 2018, 00:00

  • Clinical Core Outcomes Sets in Real World Data

    May 1, 2018, 00:00

  • Estimating the Cost and Cost-Effectiveness for Obstetric Fistula Repair in Low-Income Countries

    May 1, 2018, 00:00

  • Dose-Response Association Between Concurrent Opioid and Benzodiazepine use and Risk of Opioid- Related Overdose

    May 1, 2018, 00:00

  • Costs Related to Infusion Therapy Room and Staff for Rheumatoid Arthritis in a Specialized Center

    May 1, 2018, 00:00

  • Health Techonolgy Assessment (HTA) Agencies Consideration of Real World Evidence (RWE)

    May 1, 2018, 00:00

  • Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017)

    May 1, 2018, 00:00

  • Assessment of Anticholinergic Burden scales and Measures for Estimating Anticholinergic Exposure in Retrospective u.s. Database Analyses

    May 1, 2018, 00:00

  • Emergent Therapies And Egfr Mutation Testing In Non-Small Cell Lung Cancer- Real-World Practices

    May 1, 2018, 00:00

  • Nasal Glucagon Saves Professional Emergency Medical (EM) Costs Versus Intramuscular Glucagon —A Us Based Cost-Offset Model

    May 1, 2018, 00:00

  • A Qualitative Study to Explore the Content Validity of Patient-Reported Outcome Measures in a Systemic Lupus Erythematosus Population

    May 1, 2018, 00:00

  • Modeling the Reduction in the Clinical Burden of Migraine with Erenumab Treatment

    May 1, 2018, 00:00

  • Evaluation On Use Of Digital Refill Reminders On Patient Adherence To Antiretroviral Medications

    May 1, 2018, 00:00

  • A Cross Sectional Study of the Factors that Affect Therapy Adherence in Children with Attention Deficit Disorder/ Attention Deficit/Hyperactivity Disorder

    May 1, 2018, 00:00

  • Impact of the Affordable Care Act (ACA)’S Elimination of Cost-Sharing Provision on the Guideline-Recommended Cancer Preventive Screenings in the United States

    May 1, 2018, 00:00

  • Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR

    May 1, 2018, 00:00

  • Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia

    May 1, 2018, 00:00

  • Assessing Multi-Criteria Decision Analysis (MCDA) Attribute Weights Using an Interactive Data Capture Tool

    May 1, 2018, 00:00

  • Pharmaceutical Expenditures, out of Pocket Costs, and Impact of Provider Factors- Intersection of Health Economics and the Marketing Mix

    May 1, 2018, 00:00

  • A Systematic Review of Clinical Efficacy Associated with use of Protease-Modulating Interventions with Diabetic Foot Ulcer or Venous Leg Ulcer

    May 1, 2018, 00:00

  • An Economic Evaluation of Conservative Management and Cryotherapy in Patients with Localized Prostate Cancer

    May 1, 2018, 00:00

  • A Systematic Review of Health Economic Evaluations in Mexico

    May 1, 2018, 00:00

  • Cost-Effectiveness of Breast Cancer Screening Program in the Republic of Kazakhstan

    May 1, 2018, 00:00

  • Profiles Of Non-Small Cell Lung Cancer Patients Treated With Immuno-Oncology Therapies In The United States And Western Europe

    May 1, 2018, 00:00

  • A Tale of Two Universal Health Insurance Schemes in One Country- Horizontal Inequality of Government Medical and Pharmaceutical Benefits for Australian Children

    May 1, 2018, 00:00

  • Bayesian Network Meta-Analysis of Treatments in Iron Deficiency Anaemia (IDA)

    May 1, 2018, 00:00

  • Challenges in Research and Health Technology Assessment of Rare Disease Technologies- Report of the ISPOR Rare Disease Special Interest Group

    May 1, 2018, 00:00

  • Emergency Department (ED) Utilization for Dental Or Oral Health Related Conditions (DOHRC) Before and after Implementation of Affordable Care Act (ACA)

    May 1, 2018, 00:00

  • Trends in Prescription Opioid Use Among Hemodialysis Patients in the United States, 2007-2014

    May 1, 2018, 00:00

  • Development and Preliminary Assessment of the Environment-Based Quality Of Life (EBQOL) Instrument

    May 1, 2018, 00:00

  • Cost of Care for Patients with Metastatic Castration-Resistant Prostate Cancer in US Commercially Insured and Medicare Supplement Plans

    May 1, 2018, 00:00

  • Evaluating and Valuing Drugs for Rare Conditions- No Easy Answers

    May 1, 2018, 00:00

  • Systematic Review of Diagnosis and Treatment of Obesity and Bing- Eating Syndrome

    May 1, 2018, 00:00

  • Comparative Effectiveness of Second-Line Anti-Diabetic Agents in Delaying Treatment Intensification

    May 1, 2018, 00:00

  • Cost-Effectiveness of Niraparib and Olaparib as Maintenance Therapy for Patients with Platinum Sensitive Recurrent Ovarian Cancer

    May 1, 2018, 00:00

  • Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States

    May 1, 2018, 00:00

  • The Effect of Generic Statin Availability on Initial Statin Prescribing Trends Among Medicare Beneficiaries

    May 1, 2018, 00:00

  • Budget Impact Analysis of Implementing 5mm Dual-Ended Safety Pen Needles for Insulin Injections in US Hospitals

    May 1, 2018, 00:00

  • Overall Treatment Satisfaction with Schizophrenia Therapies- Analysis from Patient, Physician and Caregiver Perspectives

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Commonly Used Biologic Drugs for the Treatment of Moderate-To-Severe Psoriasis in the United States

    May 1, 2018, 00:00

  • The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Budget Impact Analysis of Basaglar for the Treatment of Type 1 and Type 2 Diabetes in Patients Eligible for a Long-Acting Insulin Analog

    May 1, 2018, 00:00

  • Evaluating Different Indirect Treatment Comparison Approaches- A Case Study in Acute Myeloid Leukemia Patients Ineligible to Receive Intensive Chemotherapy

    May 1, 2018, 00:00

  • Do Us Payers Consider Cost-Effectiveness when Defining Prescription Benefits? A Study of Targeted Therapies for Rheumatoid Arthritis and Moderate-To-Severe Psoriasis

    May 1, 2018, 00:00

  • Tumor Necrosis Factor Inhibitor Therapy and The Risk of Developing Depression Among Working-Age Adults with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib for Third-Line Metastatic Colorectal Cancer (MCRC) Compared to Cetuximab Plus Irinotecan in China

    May 1, 2018, 00:00

  • Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients- The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results

    May 1, 2018, 00:00

  • Real World Data Analysis of US Claims Database on Coagulation Factor IX Expenditures in Patients with Hemophilia B- Standard half-Life Vs. Extended Half-Life Products

    May 1, 2018, 00:00

  • A Comparison Of Patient Level Data (IPD) Regression Techniques In Adjusting For Cross Trial Differences In An Indirect Treatment Comparison (ITC)- A Worked Example Of Simulated Treatment Comparison (STC) Vs Bayesian Ipd Regression

    May 1, 2018, 00:00

  • A Modified Parametric Approach to Model Long-Term Survival of Potentially Curative Therapies- Implications for the Cost-Effectiveness of Car-T Therapies

    May 1, 2018, 00:00

  • Effect of a Provider-Focused Asthma Care Quality Improvement Program on Patient-Level Asthma-Related Health Care Costs

    May 1, 2018, 00:00

  • Relationship Between Patient Characteristics and Length of Stay for Severe Burn Patients- Analysis of the American Burn Association National Burn Repository

    May 1, 2018, 00:00

  • Editorial Board

    May 1, 2018, 00:00

  • Financial Impact and Experience with General Medical Services Among Cancer Survivors in the United States

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib and Tas-102 In Refractory Metastatic Colorectal Cancer

    May 1, 2018, 00:00

  • Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Eviden The Case of Second Line Treatment for Ovarian Cancer

    May 1, 2018, 00:00

  • Evaluation of Current And Future PD-(L)1 Testing Requirements in the US

    May 1, 2018, 00:00

  • Influence Of Critical Disease Insurance (CDI) Policy On Pemetrexed Adherence Among The First-Line Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Patients In Zhejiang Province Of China

    May 1, 2018, 00:00

  • Utilization Evaluation of Antibiotics at Critical Care Setting of a Tertiary Care Hospital

    May 1, 2018, 00:00

  • Economic Value Tool Evaluating Total Procedural Costs Associated with the Creation of Colorectal Anastomoses

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Low Back Pain- A Systematic Review

    May 1, 2018, 00:00

  • Missed Opportunities for Influenza and Pneumococcal Vaccinations in the Elderly in the US - A Cross-Sectional Analysis

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sequential Treatment Strategies with Tnf-Inhibitors in Patients with Ankylosing Spondylitis- A Patient-Level Simulation Model

    May 1, 2018, 00:00

  • Differences in the Flexibility of Muscles of Athletes Doing Weight Training and Functional Training

    May 1, 2018, 00:00

  • New Oral Anticoagulants And The Risk Of Vasculitis- A Nested Case-Control Study

    May 1, 2018, 00:00

  • Cost Treatment Comparison of Abiraterone Acetate Plus Prednisone in the Pre-Chemotherapy Setting Followed by Enzalutamide in the Post-Chemotherapy Setting Versus the Opposite Treatment Sequence in Metastatic Castration-Resistant Prostate Ca ...

    May 1, 2018, 00:00

  • Measuring the Extent and Impact of Disease Sub-Specialization Among Neurologists in the US

    May 1, 2018, 00:00

  • A Systematic Literature Review of Methodology to Determine Treatment Persistence in Inflammation and Immunology Observational Database Studies

    May 1, 2018, 00:00

  • Market Access for Advanced Therapy Medicinal Products (ATMPS) Begins at the Bench

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daratumumab, Lenalidomide, and Dexamethasone (DRD) and Daratumumab, Bortezomib, And Dexamethasone (DVD) Versus Standard of Care in Relapsed or Refractory Multiple Myeloma (RRMM)

    May 1, 2018, 00:00

  • Updated New Drugs Approval Timing in Italy (2015-2017)

    May 1, 2018, 00:00

  • Non-Inferiority Clinical Trial Design, Drug Approval, and Implications For Clinicians in Prescribing Oral Anticoagulants

    May 1, 2018, 00:00

  • Prevalence of Anxiety Symptoms and its Correlates Among Medical Students in China- A National Survey in 33 Universities

    May 1, 2018, 00:00

  • Pharmacoeconomics in Nepal- Need For A Paradigm Shift

    May 1, 2018, 00:00

  • Economic Evaluation of Enterex® IMX, A Specialized Nutrition Supplement Containing Arginine, in the Treatment of Neurocritical Patients in México

    May 1, 2018, 00:00

  • Adverse Drug Reactions (ADRS) Associated with Medications used to Treat HIV/AIDS- 2001-Present

    May 1, 2018, 00:00

  • What Is The Future Of Indication-Based Pricing And Contracting (IBPC) For Market Access Of New Oncologic And Biologic Agents In Major Global Markets?

    May 1, 2018, 00:00

  • Challenges in Valuing Temporary Health States for Economic Evaluation- A Review of Empirical Applications of the Chained Time Trade-Off Method

    May 1, 2018, 00:00

  • Growth of Hospital-Owned Specialty Pharmacies- Importance and Implications for Manufacturer Channel and Patient Access Strategies

    May 1, 2018, 00:00

  • Latest Insights on the Cost Efficiency of Therapeutic Plasma Exchange in Treating Guillain-Barre Syndrome

    May 1, 2018, 00:00

  • Relative Clinical and Economic Burden of Community Acquired Pneumonia in the Elderly

    May 1, 2018, 00:00

  • The Impact of Patient-Centered Medical Home on Hypertension-Associated Health Care Utilization and Cost

    May 1, 2018, 00:00

  • Budget Impact Analysis of the Advance Lubricath® Foley Catheter Tray® for Urinary Catheterization of Long Duration in Mexico

    May 1, 2018, 00:00

  • Inclusion of Drugs in a Formulary- A Case Study

    May 1, 2018, 00:00

  • Squaring the Circle? Using Real World Data from Early Access Programs to Inform Pricing and Reimbursement Decision Making

    May 1, 2018, 00:00

  • Factors Predicting Restrictions on US Commercial Payer Coverage of Specialty Drugs

    May 1, 2018, 00:00

  • Predictive Model Directed Interventions Improve Medication Adherence Program Efficiency

    May 1, 2018, 00:00

  • Risk of Diabetes Among Intensive and Moderate Dose Statin Users with Potential Modifying Effects of Treatment Duration

    May 1, 2018, 00:00

  • Infant Mortality from Acute Respiratory Infections and Armed Conflict- An Exploratory Analysis

    May 1, 2018, 00:00

  • Simultaneous Development of Patient-Reported Outcome Measures for Masseter Muscle Hypertrophy in An Asia Population

    May 1, 2018, 00:00

  • Perceived Cancer Risk and Evaluation of Public Awareness of Direct-to-Consumer Genetic Tests in the United States

    May 1, 2018, 00:00

  • Market Access Challenges and Opportunities for Anti-Infectives- An EU5 Perspective

    May 1, 2018, 00:00

  • Utilization, Spending, and Prices Trends for Anti-Epileptic Drugs (AEDS) in the U.S. Medicaid Programs- Empirical Data Analysis from 2010 to 2016

    May 1, 2018, 00:00

  • Racial Disparity in the Use of First-Line Psychosocial Care For Children and Adolescents Initiating Therapy on Antipsychotics

    May 1, 2018, 00:00

  • Cost-Effectiveness and Return on Investment of Continuous Lateral Rotation Therapy to Prevent Ventilator-Associated Pneumonia and Pressure Injuries in the Critical Care Setting

    May 1, 2018, 00:00

  • Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines- A Retrospective Cohort Analysis

    May 1, 2018, 00:00

  • Patterns of Treatment and Recurrence In Patients with Non-Metastatic Melanoma WHO Underwent Lymph Node Dissection Surgery

    May 1, 2018, 00:00

  • Long-Term Benefits of Employee Wellness Programs- A Blue Cross Blue Shield of Louisiana (BCBSLA) Case Study

    May 1, 2018, 00:00

  • Real-World Treatment Patterns For Patients With Head And Neck Squamous Cell Carcinoma (HNSCC) Treated With Immuno-Oncology (IO) Therapy

    May 1, 2018, 00:00

  • Pneumococcal Vaccines Produce Substantial Cost-Savings in Mexico

    May 1, 2018, 00:00

  • Patient Characteristics And Treatment Patterns From Spear-Bladder- Study Informing Treatment Pathway Decision In Bladder Cancer

    May 1, 2018, 00:00

  • Cost-Effectiveness of Transcathether Aortic Valve Implantation with the New Repositionable Self-Expandable Evolut R Versus Corevalve System in Inoperable Patients with Severe Aortic Stenosis in Mexico

    May 1, 2018, 00:00

  • Converting Eortc QLQ-C30 Scores To EQ-5D Utility Scores in the Brigatinib Alta Study

    May 1, 2018, 00:00

  • Adherence Issues in Osteoarthritis- How can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Ventilator-Associated Pneumonia- Validity of Quality Metrics and Outcomes of Current Practices

    May 1, 2018, 00:00

  • Globalization Module for A Diabetes Progression Prediction Model- The Building, Relating, Acting, and Validating Outcomes (Bravo) Model

    May 1, 2018, 00:00

  • Time for Reimbursement for Orphan Drugs in EU5

    May 1, 2018, 00:00

  • Evaluating A Conceptual Platform for Facilitating and Scaling Pharmaceutical Risk Sharing Arrangements

    May 1, 2018, 00:00

  • Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model- the Case of Second-Line Treatment in Patients with Ovarian Cancer

    May 1, 2018, 00:00

  • Validation of a Claims-Based Algorithm for Identification of Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) in the US

    May 1, 2018, 00:00

  • Identifying Community-Reported Health Priorities Using Free Listing Interviews in a Mixed Methods Approach

    May 1, 2018, 00:00

  • Cost-Effectiveness of a Fixed-Dose Combination Therapy of Lesinurad and Allopurinol for Second-Line Gout Therapy- A US Payer Perspective

    May 1, 2018, 00:00

  • Identifying Priority Regions for Improving Treatment Options for Illicit Drug Dependence

    May 1, 2018, 00:00

  • Commercialising Regenerative Medicines in the US – What Lessons can We Learn from Europe?

    May 1, 2018, 00:00

  • Hypoactive Sexual Desire Disorder (HSDD) is not “The Female Erectile Dysfunction (ED)”- Challenges with the Characterization of HSDD in Women

    May 1, 2018, 00:00

  • Low Birth Weight in Newborns and Associated Maternal and Neonatal Factors in a Colombian Gineco-Obstetrical Hospital

    May 1, 2018, 00:00

  • Characteristics and Rate of Subsequent Lumbar Spine Fusion Surgery Among Patients Treated with Allogenic Cellular Bone Matrix for Posterior Lumbar Spinal Fusion

    May 1, 2018, 00:00

  • Price Analysis of Immunosuppressants Which are Approved By FDA as Anti-Rejection Therapy for Kidney Transplantation in the United States

    May 1, 2018, 00:00

  • A Predictive Modeling Approach that Accurately Identifies Members with the Likelihood of Having a Future Costly Event

    May 1, 2018, 00:00

  • Cost - Effectiveness Analysis of Ultrasound Screening for Thyroid Cancer in Asymptomatic Population

    May 1, 2018, 00:00

  • A Value Of Information (VOI) Analysis Of Evolocumab For The Prevention Of Cardiovascular Deaths And Incidences In Secondary Prevention Patients

    May 1, 2018, 00:00

  • The Cost-Effectiveness Analysis of Rhtpo Versus Il-11 on The Treatment of Chemotherapy-Induced Thrombocytopenia Patients in China

    May 1, 2018, 00:00

  • Deficit of the Hungarian Health Insurance Fund Between 1994-2014

    May 1, 2018, 00:00

  • New Estimates of the Willingness-to-Pay for a Statistical Life Year- A Systematic Review of the Empirical Economic Literature

    May 1, 2018, 00:00

  • A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors

    May 1, 2018, 00:00

  • The Total Direct Healthcare Expenditures of Diagnosed Drug Dependen Evidence from United States National Survey Data

    May 1, 2018, 00:00

  • Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Patient and Provider Characteristics Associated with PHQ-9 Administration and Outcomes Assessment in Routine Clinical Practi Findings from the OM1 Data Cloud

    May 1, 2018, 00:00

  • Readiness of Community Oncology and Urology Practices for Value-Based Care

    May 1, 2018, 00:00

  • An Exact Method For Estimating Standard Errors From Zero-Inflated Gamma Distributions For Healthcare Cost Data

    May 1, 2018, 00:00

  • A Review of Definition of Smoking Status When Using Electronic Medical/Health Records and Claims Databases In Studies

    May 1, 2018, 00:00

  • The Role of General Practitioners During Economic Crises

    May 1, 2018, 00:00

  • The Economic Burden of Varicella in Mexico

    May 1, 2018, 00:00

  • Perceptions of Cost Pressure Associated with Biosimilars Among Physicians in Europe

    May 1, 2018, 00:00

  • Effectiveness of the Treatment with New Antivirals in Adult Patients with Chronic Infection with Hepatitis C Virus in Colombia During 2016-2017

    May 1, 2018, 00:00

  • Developing Content for a New Generic Qaly Measure- Results from a Qualitative Literature Review (E-Qaly Project)

    May 1, 2018, 00:00

  • Drug Utilization Review of Acute Coronary Syndrome Patients in Hong Kong and United States

    May 1, 2018, 00:00

  • Adherence and Persistence with Antiplatelet Agents in Patients with New Episode of Acute Coronary Syndrome in Tianjin, China

    May 1, 2018, 00:00

  • Testosterone Replacement Therapy Reduces Cardiovascular Events in Men with Chronic Kidney Disease

    May 1, 2018, 00:00

  • Use of Anti-Diabetic Medication is Not Associated with Cancer Risk in Chinese Patients with Type 2 Diabetes

    May 1, 2018, 00:00

  • Cost-Benefitanalysis of Hepatitis B Vaccination Strategies for Preventing Mother-to-Child Transmission：A Decision Tree-Markov Model

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Nilotinib Versus High-Dose Imatinib for the Second-Line Treatment of Chronic Myeloid Leukemia In China - Based on Nation-Wide Data

    May 1, 2018, 00:00

  • Interseizure Interval In Frequently Admitted Epilepsy Patients

    May 1, 2018, 00:00

  • Small Changes, Big Differences? Cohort Variation by Parameter Specifications in Claims-Based Drug use Evaluations

    May 1, 2018, 00:00

  • Economic Impact of Treatment Adherence in Exocrine Pancreatic Insufficiency (EPI) Patients Treated with Pancreatic Enzyme Replacement Therapy (PERT)

    May 1, 2018, 00:00

  • Opioid Use Among Patients Presenting with Migraine in the Emergency Department

    May 1, 2018, 00:00

  • A Review of Patient-Reported Outcomes in Nonalcoholic Steatohepatitis (NASH)

    May 1, 2018, 00:00

  • Anti-Vegf Dosing Intervals in Patients with Neovascular Age-Related Macular Degeneration- a Retrospective Cohort Study in Australia

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hereditary Angioedema- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Reimbursement Landscape for Molecular Testing in Non-Small Cell Lung Cancer (NSCLC) in the United States

    May 1, 2018, 00:00

  • Extended Thromboprophylaxis With Betrixaban Is Cost-Effective In Acutely ILL Medical Patients

    May 1, 2018, 00:00

  • Efficacy and Safety of Vedolizumab in the Treatment of Ulcerative Colitis- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Costs Among Commercially Insured Patients with Juvenile Idiopathic Arthritis (JIA) in the United States

    May 1, 2018, 00:00

  • Parent and Adult Patient Attitudes About Gene Therapy as a Therapeutic Option for Duchenne Muscular Dystrophy

    May 1, 2018, 00:00

  • Copyright/Subscription

    May 1, 2018, 00:00

  • Effect of Patient Involvement in Treatment Decision Making on Disease Outcomes in Rheumatoid Arthritis in the EU5

    May 1, 2018, 00:00

  • Cost - Effectiveness of the use of the Insulin Pump Therapy Versus Daily Multiple Injections in Patients with Type 1 Diabetes at the Mexican Institute of Social Security

    May 1, 2018, 00:00

  • Demographic Variation of Hepatitis C Virus (HCV) Prevalence in the US- Results from the National Health and Nutrition Examination Survey 2009 – 2016

    May 1, 2018, 00:00

  • Budget Impact Analysis For Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Costa Rica

    May 1, 2018, 00:00

  • Prediction of Health Utility Scores in Patients with Chronic Hepatitis C Using the Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV)

    May 1, 2018, 00:00

  • Factors Associated with Data Collection Duration and Participation Rates in Retrospective Noninterventional Medical Record Review Studies

    May 1, 2018, 00:00

  • Cost-Effectiveness of Abaloparatide for the Treatment of Postmenopausal Women with Osteoporosis

    May 1, 2018, 00:00

  • Complications Related Health Utility Decrements for Type 2 Diabetes Population in the United States

    May 1, 2018, 00:00

  • Creating a Flexible Continuous Procedure Distribution Model Based on Pre-Test Risk Level for Lung Cancer in Patients with Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00

  • Adherence Issues in COPD- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Adherence and Persistence in Medication Assisted Treatment Among Pregnant Women with Opioid use Disorder

    May 1, 2018, 00:00

  • The Economic Impact of Shingles Vaccine Disparities Among Hispanics

    May 1, 2018, 00:00

  • Resource Use Related to Pediatric Lower Limb Spasticity in Canada- Physician Questionnaire

    May 1, 2018, 00:00

  • Changes in Healthcare Resource use and Costs Associated with the use of Adjunctive Atypical Antipsychotics In Major Depressive Disorder

    May 1, 2018, 00:00

  • Analyzing Prescription Data to Target Hard-To-Identify Patient Populations for Clinical Trials- A Case Study in Narcolepsy

    May 1, 2018, 00:00

  • Treatment Practice Patterns, Healthcare Resource Utilization (HRU), and Costs in Newly Diagnosed Patients with Therapy-Related Acute Myeloid Leukemia (TAML) or AML with Myelodysplasia-Related Changes (AML-MRC) in a United States (US) Commer ...

    May 1, 2018, 00:00

  • Estimation of Total Burden of Bladder Cancer in Brazil – An Economic and Clinical Approach

    May 1, 2018, 00:00

  • Economic Evaluation of Recombinant Factor VIII FC Fusion Protein (RFVIIIFC) for Immune Tolerance Induction (ITI) in Patients with Hemophilia a WHO Develop Inhibitors Under the Brazilian Unified Health System (SUS) Perspective

    May 1, 2018, 00:00

  • The Burden of Sickle Cell Disease

    May 1, 2018, 00:00

  • Does Exposure to Health Valuation Tasks Impact One’s Self Rated Health?

    May 1, 2018, 00:00

  • Measurement Equivalence of Patient-Reported Outcome Measure Response Scale Types Collected Using Bring Your Own Device Compared to Paper and a Provisioned Device- Results of a Randomized Equivalence Trial

    May 1, 2018, 00:00

  • Utilization of a Precise, Clinically Relevant, Digital Classification System to Identify Variation in Care and Costs Among Patients with Breast Cancer

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Enzalutamide and Abiraterone for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00

  • Budget Impact Analysis of two Approved Therapies for Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00

  • Evaluation of Modified Item Characteristics on Item Comprehension and Psychometric Performance

    May 1, 2018, 00:00

  • Effect of Cash Prescriptions on Statin, Antihypertensive, And Antidiabetic Medication Adherence Estimates in the Commercially-Insured Population

    May 1, 2018, 00:00

  • Healthcare Resource Utilization Among Patients with Angelman Syndrome Stratified By Age

    May 1, 2018, 00:00

  • Total Costs Distribution for Multiple Myeloma in Single Upper Middle Income Country- Is Cost Data Distribution Comparable with High Income Countries?

    May 1, 2018, 00:00

  • Early Check- A Voluntary Newborn Screening Program and Research Registry to Facilitate Clinical Trials in Pre-Symptomatic Infants with Rare Diseases

    May 1, 2018, 00:00

  • Budget Impact Analysis of Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer Patients Progressing after Docetaxel in the Mexican Public Healthcare System

    May 1, 2018, 00:00

  • Persistence and Adherence at 12 Months with Subcutaneously Administered Biologics Among Biologic-Naive and -Experienced Patients With Psoriatic Arthritis- Analyses From A Us Claims Database

    May 1, 2018, 00:00

  • Do Medical Homes Affect Healthcare Utilization Rates? A Longitudinal Evaluation on Medical Home Implementation in Italy

    May 1, 2018, 00:00

  • Statins Adherence And Its Risk Factors Analysis in Chinese Ascvd Patients Based on A Provincial Claim Data

    May 1, 2018, 00:00

  • Medication Usage, Length of Stay, and Hospital Charges in Bipolar Disorder Patients- A Retrospective Analysis of a Large Us Electronic Health Record Database

    May 1, 2018, 00:00

  • Incremental Burden of Diabetes Complications on Quality of Life and Healthcare Expenditures in the United States

    May 1, 2018, 00:00

  • Comparing the Costs and Outcomes of a Twin Interlocking Derotation and Compression Screw Cephalomedullary Nail (2-Screw Nail)* with a Single Screw Cephalomedullary Nail (Single-Screw Nail) in Patients with Intertrochanteric HIP Fractures

    May 1, 2018, 00:00

  • Inpatient Admission Length Of Stay And Costs Among Vascular Procedure Patients Receiving Perclose Proglide Suture-Mediated Closure Compared To Patients Receiving Surgical Cutdown For Closure Of Large Bore Arterial Access

    May 1, 2018, 00:00

  • Reviewing Adverse Drug Event Reporting Between Randomized Clinical Trial Data and Real World Post Market Data for Sorafenib and Sunitinib

    May 1, 2018, 00:00

  • Payer Perspectives on Gene Therapy Reimbursement in the United States

    May 1, 2018, 00:00

  • Unmet Needs in the Management of Hypoactive Sexual Desire Disorder in Premenopausal Women

    May 1, 2018, 00:00

  • Real World Practice and Patient-Reported Outcomes of Uncontrolled Hypertensive Patients In Korea

    May 1, 2018, 00:00

  • Comparison of Healthcare Resource Utilization and Clinical Status Among Type 2 Diabetes Patients Using Multiple-Daily Injection (MDI) Insulin Therapy Versus Non-Mdi Therapy

    May 1, 2018, 00:00

  • Estimated Budget Impact Of Cholesterol Decreasing In The Russian Population

    May 1, 2018, 00:00

  • Disease Burden and Integreted Disease Management of Biologic Treated Psoriasis Patients with Psoriatic Arthritis in Clinical Practi Results from Multicountry Study in EU5

    May 1, 2018, 00:00

  • Challenges in Outlier Surgeon Assessment in the Era of Public Reporting

    May 1, 2018, 00:00

  • Modeling the Public Health Impact of Varicella Vaccination in Argentina- Implications of Vaccine Choice and Dosing Schedules

    May 1, 2018, 00:00

  • Cost-Effectiveness of Empagliflozin in Chinese Patients with Type 2 Diabetes and Established Cardiovascular Disease- A Discrete Event Simulation Economic Modelling Study

    May 1, 2018, 00:00

  • Cost Effectiveness Of Direct Oral Anticoagulants (DOACS) Compared With Warfarin- A Literature Review

    May 1, 2018, 00:00

  • Reimbursement Decision-Making in Ukraine- Current and Future Directions

    May 1, 2018, 00:00

  • Cost-Effectiveness Evaluation of Ertapenem in the Treatment of Adult Patients with Community-Acquired Complicated Intraabdominal Infection

    May 1, 2018, 00:00

  • The Costs of Intensifying Type 2 Diabetes Patients Treated with Basal Insulin to Basal in Combination with GLP-1- A Physician Survey

    May 1, 2018, 00:00

  • Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada

    May 1, 2018, 00:00

  • Comparing Cost-Per-Qalys Gained And Cost-Per-Dalys Averted Analyses

    May 1, 2018, 00:00

  • Economic Burden of Infant-Onset (Type 1) Spinal Muscular Atrophy- A Retrospective Claims Database Analysis

    May 1, 2018, 00:00

  • Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis- A Systematic Review

    May 1, 2018, 00:00

  • Evaluation of Cost of Hospitalizations Related to Nausea and Vomiting Among Cancer Patients

    May 1, 2018, 00:00

  • Association of Treatment Resistant Depression with Healthcare Resource Utilization and Physician Satisfaction with Disease Management

    May 1, 2018, 00:00

  • Impact of V-Go Versus Multiple Daily Injections on Glycemic Control, Insulin Utilization and Healthcare Costs Among Individuals with Type 2 Diabetes Mellitus

    May 1, 2018, 00:00

  • The Direct Cost Burden of Tuberous Sclerosis Complex Among Insured Patients in the US

    May 1, 2018, 00:00

  • Prevalence, Disease Burden and Unmet Needs of Patients With Essential Tremor- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Non-Adherence to Antipsychotics and Disease Comorbidity- A Double Whammy in Schizophrenia Management

    May 1, 2018, 00:00

  • Global Burden of Seasonal Influenza Disease- A Structured Literature Review

    May 1, 2018, 00:00

  • The Association Between Adherence with Statin Therapy and Risk of Dementia Among Diabetic Patients with Comorbid Hyperlipidemia

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Bronchial Thermoplasty Versus Pharmacological Therapies in Patients with Severe Asthma in Mexico, Colombia and Spain

    May 1, 2018, 00:00

  • Valuing Health-Related Quality of Life for Inpatients with Diabetes-Related Complications In China

    May 1, 2018, 00:00

  • Demonstration of Ngram Frequency and Cluster Method for Identifying Signals of Transfusion Reactions (TR)

    May 1, 2018, 00:00

  • An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma

    May 1, 2018, 00:00

  • Characterizing the Clinical and Economic Burden of Type 2 Diabetes (T2DM) Patients on Multiple Daily Injections (MDI) of Insulin- A Systematic Literature Review

    May 1, 2018, 00:00

  • Real World Experience with Calcipotriene and Betamethasone Dipropionate Foam 0.005%/0.064% (Cal/BD Foam) in the Treatment of Adult Psoriasis Including Psoriasis Itch from Retrospective Chart Review

    May 1, 2018, 00:00

  • Chi-Square Automatic Interaction Detection (CHAID) Analysis- Understanding and Informing Treatment Choice of Second-Line Metastatic Urothelial Cancer Therapy

    May 1, 2018, 00:00

  • Hospitalization Outcomes For Adults In The United States With Atrial Septal Defect- Analysis Of A Multicenter Database

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Injectable Paliperidone Palmitate 3-Month Formulation Versus Injectable Risperidone and Oral Antipsychotics For The Treatment Of Schizophrenia In Colombia

    May 1, 2018, 00:00

  • Serum Autoantibodies Multi-Testing in Rheumatoid Arthritis in Primary Care can Reduce Avoidable Costs Associated to False Positives. A Simulation Study in the United States of America

    May 1, 2018, 00:00

  • Psychometric Validation of the 1-Month Recall Uterine Fibroid Symptom and Health-Related Quality-of-Life Questionnaire

    May 1, 2018, 00:00

  • Health Care Utilization and Economic Burden of Patients With Inflammatory Bowel Disease in the US Department of Defense Population

    May 1, 2018, 00:00

  • Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany

    May 1, 2018, 00:00

  • New Drugs Approval in Italy- Updated Analysis of the Applied Negotiation Conditions 2015-2017

    May 1, 2018, 00:00

  • Economic Impact of Dengue in Brazil Over 10 Years (2008-2017)

    May 1, 2018, 00:00

  • A Review of Health Technology Assessments (HTA) of PCSK9 Inhibitors (PSCK9I)

    May 1, 2018, 00:00

  • Trends in Baseline Retinal Examinations and Associated Factors Among New Initiators of Hydroxychloroquine in Medicare- 2011-2015

    May 1, 2018, 00:00

  • Humanistic And Economic Burden Associated With Anxiety And Depression Among Adults With Diabetes And Hypertension

    May 1, 2018, 00:00

  • A Review of the International New Drug Landscape

    May 1, 2018, 00:00

  • The Prevalence and Treatment Patterns of Women of Child Bearing Age (WOCBA) with Psoriasis (PSO)

    May 1, 2018, 00:00

  • Methods for Reporting the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Data in Cancer Clinical Trials

    May 1, 2018, 00:00

  • Access to Patient-Centered Medical Home Care Among Adults with Chronic Conditions- Findings from the Medical Expenditures Panel Survey

    May 1, 2018, 00:00

  • Predictors and Incidence of Cardiovascular Events in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Lifetime Cost-Effectiveness of Adjuvant External Beam Whole Breast Irradiation (EBWBI) in Estrogen Receptor Positive (ER+) Early-Stage Breast Cancer (ESBC) Women- Cardiotoxicity Consideration

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Regorafenib in Patients with Advanced Hepatocellular Carcinoma

    May 1, 2018, 00:00

  • Is Self-Rated Health of Americans Different in 2017 Compared to 2002?

    May 1, 2018, 00:00

  • Systematic Literature Review of Treatments for Patients with Untreated Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Resource use of Patients Diagnosed with Schizophrenia- Analysis of Physician Record form Data in the United States

    May 1, 2018, 00:00

  • Alirocumab Possession Among Medicare Advantage Patients

    May 1, 2018, 00:00

  • How Health Technology Assessment Programs Take Into Account the Patient Perspective in Healthcare Decision Making- Comparison Between the United States and Several European Countries

    May 1, 2018, 00:00

  • Costs and Healthcare Resource Utilization Associated with Hospital Admissions of Prostate Cancer Patients With or without Metastasis

    May 1, 2018, 00:00

  • Hospital Related Clinical and Economical Outcomes of a Bicruciate Knee System in Total Knee Arthroplasty Patients

    May 1, 2018, 00:00

  • Health Behaviors Among Stroke Survivors In The United States- A Propensity Score Matched Study

    May 1, 2018, 00:00

  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Peru

    May 1, 2018, 00:00

  • Economic Burden Of Renal Cell Carcinoma Among Older Adults In The Targeted Therapy ERA

    May 1, 2018, 00:00

  • Impact Of Dining Out And Food Intake Pattern On Atrial Fibrillation Prevalence In Hong Kong Chinese Elders

    May 1, 2018, 00:00

  • Using Machine Learning to Predict Opioid Overdoses Among Prescription Opioid Users

    May 1, 2018, 00:00

  • Medical Expenditures for Patients with Pulmonary Embolism Among the Population with Urban Basic Health Insurance in China

    May 1, 2018, 00:00

  • Selecting Health States for EQ-5D-3L Valuation Studies- Statistical Considerations Matter

    Apr 1, 2018, 00:00

  • Table of Contents

    Apr 1, 2018, 00:00

  • A Framework for Measuring Low-Value Care

    Apr 1, 2018, 00:00

  • Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom

    Apr 1, 2018, 00:00

  • Sustained 3-Year Benefits in Quality of Life After Percutaneous Coronary Interventions in the Elderly- A Prospective Cohort Study

    Apr 1, 2018, 00:00

  • Editorial Board

    Apr 1, 2018, 00:00

  • Utility-Based Instruments for People with Dementia- A Systematic Review and Meta-Regression Analysis

    Apr 1, 2018, 00:00

  • Cost of Tuberculosis Diagnosis and Treatment in Patients with HIV- A Systematic Literature Review

    Apr 1, 2018, 00:00

  • The CDI-DaySyms- Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection

    Apr 1, 2018, 00:00

  • Copyright/Subscription

    Apr 1, 2018, 00:00

  • Modeling Clinical Outcomes in Prostate Cancer- Application and Validation of the Discrete Event Simulation Approach

    Apr 1, 2018, 00:00

  • Are US Health Insurers Efficient or Not?

    Apr 1, 2018, 00:00

  • The Use of MCDA in HTA- Great Potential, but More Effort Needed

    Apr 1, 2018, 00:00

  • Assessment of Reliability and Validity of SF-12v2 among a Diabetic Population

    Apr 1, 2018, 00:00

  • A Comparison of Coverage Restrictions for Biopharmaceuticals and Medical Procedures

    Apr 1, 2018, 00:00

  • Emerging Good Practices for Transforming Value Assessment- Patients’ Voices, Patients’ Values

    Apr 1, 2018, 00:00

  • What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?

    Apr 1, 2018, 00:00

  • Improving Value for Patients with Eczema

    Apr 1, 2018, 00:00

  • The Value Challenge- Examining the Transformative Strategies to Measure or Evaluate the Value of Health Care Interventions

    Apr 1, 2018, 00:00

  • Comparing 15D Valuation Studies in Norway and Finland—Challenges When Combining Information from Several Valuation Tasks

    Apr 1, 2018, 00:00

  • The ICER Value Framework- Integrating Cost Effectiveness and Affordability in the Assessment of Health Care Value

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance

    Mar 1, 2018, 00:00

  • Associations of Smoking, Physical Inactivity, Heavy Drinking, and Obesity with Quality-Adjusted Life Expectancy among US Adults with Depression

    Mar 1, 2018, 00:00

  • Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease

    Mar 1, 2018, 00:00

  • Economic Evaluation of Treating Skeletal-Related Events among Prostate Cancer Patients

    Mar 1, 2018, 00:00

  • Table of Contents

    Mar 1, 2018, 00:00

  • What Is the Evidence from Past National Institute of Health and Care Excellence Single-Technology Appraisals Regarding Company Submissions with Base-Case Incremental Cost-Effectiveness Ratios of Less Than £10,000/QALY?

    Mar 1, 2018, 00:00

  • Paying for Cures- Perspectives on Solutions to the “Affordability Issue”

    Mar 1, 2018, 00:00

  • Sensitivity of Claims-Based Algorithms to Ascertain Smoking Status More Than Doubled with Meaningful Use

    Mar 1, 2018, 00:00

  • Resource Use and Cost of Alzheimer’s Disease in France- 18-Month Results from the GERAS Observational Study

    Mar 1, 2018, 00:00

  • Affordability of Health Care- A Global Crisis

    Mar 1, 2018, 00:00

  • Resolving the “Cost-Effective but Unaffordable” Paradox- Estimating the Health Opportunity Costs of Nonmarginal Budget Impacts

    Mar 1, 2018, 00:00

  • Editorial Board

    Mar 1, 2018, 00:00

  • Affordability Challenges to Value-Based Pricing- Mass Diseases, Orphan Diseases, and Cures

    Mar 1, 2018, 00:00

  • Copyright/Subscription

    Mar 1, 2018, 00:00

  • The Importance of Model Structure in the Cost-Effectiveness Analysis of Primary Care Interventions for the Management of Hypertension

    Mar 1, 2018, 00:00

  • Affordability of New Technologies- The Next Frontier

    Mar 1, 2018, 00:00

  • Real-World Evidence- Useful in the Real World of US Payer Decision Making? How? When? And What Studies?

    Mar 1, 2018, 00:00

  • Estimating the Learning Curve of a Novel Medical Device- Bipolar Sealer Use in Unilateral Total Knee Arthroplasties

    Mar 1, 2018, 00:00

  • Investigating the Heterogeneity in Women’s Preferences for Breast Screening- Does the Communication of Risk Matter?

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- A Missed Opportunity for ISPOR and Patients

    Feb 1, 2018, 00:00

  • The Impact of Decision Makers’ Constraints on the Outcome of Value of Information Analysis

    Feb 1, 2018, 00:00

  • Defining Elements of Value in Health Care—A Health Economics Approach- An ISPOR Special Task Force Report [3]

    Feb 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Abatacept Compared with Adalimumab on Background Methotrexate in Biologic-Naive Adult Patients with Rheumatoid Arthritis and Poor Prognosis

    Feb 1, 2018, 00:00

  • A Comparison of Different Approaches for Costing Medication Use in an Economic Evaluation

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Frameworks- Serving the Needs of Decision Making

    Feb 1, 2018, 00:00

  • Reliability, Validity, and Responsiveness of InFLUenza Patient-Reported Outcome (FLU-PRO©) Scores in Influenza-Positive Patients

    Feb 1, 2018, 00:00

  • Editorial Board

    Feb 1, 2018, 00:00

  • Review of Recent US Value Frameworks—A Health Economics Approach- An ISPOR Special Task Force Report [6]

    Feb 1, 2018, 00:00

  • Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease

    Feb 1, 2018, 00:00

  • Choice Defines Value- A Predictive Modeling Competition in Health Preference Research

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Introduction- An ISPOR Special Task Force Report [1]

    Feb 1, 2018, 00:00

  • Copyright/Subscription

    Feb 1, 2018, 00:00

  • Objectives, Budgets, Thresholds, and Opportunity Costs—A Health Economics Approach- An ISPOR Special Task Force Report [4]

    Feb 1, 2018, 00:00

  • Table of Contents

    Feb 1, 2018, 00:00

  • Corrections to ’Systematic Literature Review and Indirect Treatment Comparison of the Efficacy of Semaglutide versus Empagliflozin as Add-On to Basal Insulin (PDB4)’

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- Seeking a Role for Health Economics

    Feb 1, 2018, 00:00

  • A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]

    Feb 1, 2018, 00:00

  • An Overview of Value, Perspective, and Decision Context—A Health Economics Approach- An ISPOR Special Task Force Report [2]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- An Industry Perspective

    Feb 1, 2018, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Systematic Review and Network Meta-Analysis

    Feb 1, 2018, 00:00

  • Corrections to ‘Reporting to Improve Reproducibility and Facilitate Validity Assessment for Healthcare Database Studies V1.0’ [JVAL 20/8 (2017) 1009–1022]

    Feb 1, 2018, 00:00

  • Approaches to Aggregation and Decision Making—A Health Economics Approach- An ISPOR Special Task Force Report [5]

    Feb 1, 2018, 00:00

  • ISPOR’s Initiative on US Value Assessment Frameworks- The Use of Cost-Effectiveness Research in Decision Making among US Insurers

    Feb 1, 2018, 00:00

  • Do Surrogate Endpoints Better Correlate with Overall Survival in Studies That Did Not Allow for Crossover or Reported Balanced Postprogression Treatments? An Application in Advanced Non–Small Cell Lung Cancer

    Jan 1, 2018, 00:00

  • Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States

    Jan 1, 2018, 00:00

  • Accounting for Uncertainty in Decision Analytic Models Using Rank Preserving Structural Failure Time Modeling- Application to Parametric Survival Models

    Jan 1, 2018, 00:00

  • Table of Contents

    Jan 1, 2018, 00:00

  • Cost-Effectiveness and Value of Information Analysis of Brief Interventions to Promote Physical Activity in Primary Care

    Jan 1, 2018, 00:00

  • Conducting a Discrete-Choice Experiment Study Following Recommendations for Good Research Practices- An Application for Eliciting Patient Preferences for Diabetes Treatments

    Jan 1, 2018, 00:00

  • Editorial Board

    Jan 1, 2018, 00:00

  • Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis- An Indirect Comparison Using Individual Patient Data from Randomized Trials

    Jan 1, 2018, 00:00

  • Instructions for Authors

    Jan 1, 2018, 00:00

  • Using a Discrete-Choice Experiment Involving Cost to Value a Classification System Measuring the Quality-of-Life Impact of Self-Management for Diabetes

    Jan 1, 2018, 00:00

  • Women’s Benefits and Harms Trade-Offs in Breast Cancer Screening- Results from a Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Standards for Instrument Migration When Implementing Paper Patient-Reported Outcome Instruments Electronically- Recommendations from a Qualitative Synthesis of Cognitive Interview and Usability Studies

    Jan 1, 2018, 00:00

  • Identifying Psoriasis and Psoriatic Arthritis Patients in Retrospective Databases When Diagnosis Codes Are Not Available- A Validation Study Comparing Medication/Prescriber Visit–Based Algorithms with Diagnosis Codes

    Jan 1, 2018, 00:00

  • An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds

    Jan 1, 2018, 00:00

  • The Burden of Peristomal Skin Complications on an Ostomy Population as Assessed by Health Utility and the Physical Component Summary of the SF-36v2

    Jan 1, 2018, 00:00

  • EQ-5D- Moving from Three Levels to Five

    Jan 1, 2018, 00:00

  • EQ-5D-5L versus EQ-5D-3L- The Impact on Cost Effectiveness in the United Kingdom

    Jan 1, 2018, 00:00

  • Trading Bankruptcy for Health- A Discrete-Choice Experiment

    Jan 1, 2018, 00:00

  • Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer

    Dec 1, 2017, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions- An Illustration for Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2017, 00:00

  • Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease

    Dec 1, 2017, 00:00

  • An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions- The EQ-5D Case Study

    Dec 1, 2017, 00:00

  • Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands- A Country Adaptation Analysis Under the Former and Current Du ...

    Dec 1, 2017, 00:00

  • Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit

    Dec 1, 2017, 00:00

  • Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure- A Network Meta-Analysis

    Dec 1, 2017, 00:00

  • Table of Contents

    Dec 1, 2017, 00:00

  • Letter to the Editor- Emerging Guidelines for Patient Engagement in Research

    Dec 1, 2017, 00:00

  • Scientific Evidence in Health Technology Assessment Reports- An In-Depth Analysis of European Assessments on High-Risk Medical Devices

    Dec 1, 2017, 00:00

  • Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise

    Dec 1, 2017, 00:00

  • Copyright/Subscription

    Dec 1, 2017, 00:00

  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer- The OPTIMA Prelim Trial

    Dec 1, 2017, 00:00

  • A (Latent) Class of Their Own- Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises

    Dec 1, 2017, 00:00

  • ISPOR Code of Ethics 2017 (4th Edition)

    Dec 1, 2017, 00:00

  • Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus- A Cost-Utility Analysis

    Dec 1, 2017, 00:00

  • Editorial Board

    Dec 1, 2017, 00:00

  • Comparing Methods for Estimating Direct Costs of Adverse Drug Events

    Dec 1, 2017, 00:00

  • Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors

    Dec 1, 2017, 00:00

  • Author Response- Patient Engagement

    Dec 1, 2017, 00:00

  • Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial- An Update with Empirical Trial–Based Cost Data

    Dec 1, 2017, 00:00

  • The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies- Findings from the INITIATOR Study

    Dec 1, 2017, 00:00

  • Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation- A Multicriteria Decision Analysis

    Dec 1, 2017, 00:00

  • Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation

    Dec 1, 2017, 00:00

  • Next Edition of the ISPOR Code of Ethics- Is It Setting Us up for the Era of Digitized Health Care?

    Dec 1, 2017, 00:00

  • Development and Validation of the AFImpact- An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life

    Dec 1, 2017, 00:00

  • Reviewer Acknowledgement 20/10

    Dec 1, 2017, 00:00

  • Health Care System

    Dec 1, 2017, 00:00

  • The Role of Noncomparative Evidence in Health Technology Assessment Decisions

    Dec 1, 2017, 00:00

  • Value and Impact of Incorporating Uncertainty into Opinion Based Research- Study on American College of Medical Genetics (ACMG) Recommendations for Newborn Screening (NBS) for Cystic Fibrosis (CF)

    Oct 1, 2017, 00:00

  • Estimating The Drug Treatment Cost of Breast Cancer

    Oct 1, 2017, 00:00

  • Costs and Benefits of Implementing Non-Invasive Prenatal Testing For Trisomy 21 (T21) Based on Cell Free DNA (CFDNA) Sequencing In Maternal Plasma In France

    Oct 1, 2017, 00:00

  • The Impact Of Human Papillomavirus Vaccine In Taiwan- A Transmission Dynamic Modelling Approach

    Oct 1, 2017, 00:00

  • Patient Insights In Copd Medication Adherence From Pharmacy Data

    Oct 1, 2017, 00:00
  • «
  • 71
  • 72 (current)
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • »